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mobilization, not enhanced oxidative capacity
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Obesity is characterized by excessive rates of plasma fatty acid mobilization and uptake,
which play a key role in mediating insulin resistance. While weight loss via diet-only or a
diet + exercise program clearly improves insulin sensitivity, the precise mechanisms modulating
this improvement are not completely understood. The purpose of the present study was to
determine the role of the reduced fatty acid mobilization and uptake after weight loss in obese
women who were randomly assigned to lifestyle interventions of either weight loss without
exercise (WL) (n = 7) or a weight loss + exercise program (WL + EX) (n = 10). Before and after
losing 12% of their body weight, we measured insulin sensitivity (SI), systemic fatty acid rate of
appearance (Ra) and disappearance (Rd), oxidative capacity, and markers for pro-inflammatory
pathways in skeletal muscle. Fatty acid Ra and Rd were reduced by ∼30% after both interventions
(P < 0.05). While oxidative capacity increased 25% in WL + EX (compared with no increase
after WL), the improvement in SI was identical in both groups (∼60%; P < 0.05), and skeletal
muscle pro-inflammatory pathways were reduced (P < 0.05) similarly in both groups. When
we artificially increased fatty acid mobilization after weight loss to pre-weight-loss levels via an
overnight lipid infusion, the improvement in SI was almost completely reversed. Importantly,
WL + EX did not protect against this lipid-induced reversal in SI despite a significant increase
in resting whole-body fat oxidation and a marked increase in skeletal muscle oxidative capacity.
In conclusion, reduced fatty acid mobilization and uptake appears to be a primary mediator of
improved insulin sensitivity after weight loss. Moreover, enhancing fatty acid oxidative capacity
via exercise training is not sufficient to prevent the insulin resistance caused by high fatty acid
mobilization, such as that found in obesity.
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Introduction
Insulin resistance is among the most pervasive metabolic
complications associated with obesity, and is linked
with the pathogenesis of chronic diseases, such as
type 2 diabetes and cardiovascular disease (Facchini
et al. 2001). Weight loss through caloric restriction is
known to attenuate and even reverse insulin resistance
(Assali et al. 2001; Toledo et al. 2008; Ross et al.
2000; Janssen et al. 2002), and adding an endu-
rance exercise training program to a calorie restricted diet
has been proposed to augment improvements in insulin
sensitivity (Goodpaster et al. 2003; Toledo et al. 2007).
However, differentiating the effects of exercise training
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from the effects of weight loss is very difficult. As such, the
precise mechanisms that mediate improvements in insulin
sensitivity after a combined weight-loss–exercise training
intervention are poorly defined.
Recently, a reduced capacity of skeletal muscle to oxidize
fatty acids, as well as impairments in mitochondrial
function have been implicated as important mediators
of insulin resistance in obesity (for review, Savage et al.
2007), although some clinical studies do not support this
perspective (Ostergard et al. 2006; Boushel et al. 2007; Nair
et al. 2008). Fatty acid oxidative capacity has been found
to be lower in skeletal muscle from some obese subjects
compared with lean controls (Kim et al. 2000; Berggren
et al. 2008), and it has been hypothesized that enhancing
oxidative capacity via endurance exercise training may
be responsible for much of the improvement in insulin
sensitivity after an exercise training–weight-loss program
(Goodpaster et al. 2003; Berggren et al. 2004, 2008;
Toledo et al. 2007). Several reports, however, indicate that
moderately obese individuals (i.e. BMI: 30–40 kg m−2) do
not a have an impaired ability to oxidize fatty acids, yet
they are still insulin resistant (Hulver et al. 2003; Bonen
et al. 2004; Bandyopadhyay et al. 2006). In addition,
improvements in insulin sensitivity after weight loss in
obesity appear to occur independently of changes in
skeletal muscle fatty acid oxidation, oxidative capacity,
mitochondrial function or mitochondrial size (Berggren
et al. 2008; Toledo et al. 2008). Therefore, the impact
of alterations in oxidative capacity on insulin sensitivity
remains unclear.
Interpretation of data from studies examining the effect
of an exercise training/weight-loss program on insulin
sensitivity is further complicated because weight loss (i.e.
a reduction in fat mass) can reduce systemic fatty acid
mobilization (Klein et al. 1996; Lofgren et al. 2002), which
itself can improve insulin sensitivity (Santomauro et al.
1999; Bajaj et al. 2005). In addition, studies by Ross
and colleagues (Ross et al. 2000; Dekker et al. 2007)
have demonstrated that exercise training, and a resultant
increase in oxidative capacity, does not improve insulin
sensitivity when subjects do not lose weight. This may
be explained by the fact that exercise training without
weight loss does not reduce fatty acid mobilization and
uptake (Horowitz et al. 1999a, 2000). Moreover, when
the degree of weight loss is similar, there does not appear
to be an additional benefit of adding exercise training
to a weight-loss program to the improvement in insulin
sensitivity (Ross et al. 2000; Janssen et al. 2002), although
the mechanism(s) for these comparable improvements in
insulin sensitivity are unknown.
It has become increasingly evident that chronic,
low-grade inflammatory responses play an important role
in mediating insulin resistance in obesity (Schenk et al.
2008). For example, the activity of pro-inflammatory
serine/stress kinase pathways, such as inhibitor of kB
(IkB) kinase (IKK)–nuclear factor κB (NFκB), and c-Jun
N-terminal kinase (JNK), are elevated in skeletal muscle
in obesity and type 2 diabetes (Hirosumi et al. 2002;
Bandyopadhyay et al. 2005; Ropelle et al. 2006;
Sriwijitkamol et al. 2006). These pathways are important
because they are activated by increased fatty acid
availability and can negatively regulate insulin signalling
(Nguyen et al. 2005). Therefore, these pro-inflammatory
signals provide an intermediate molecular link between
fatty acid metabolism and insulin action. Conversely, en-
durance training in obese, diabetic subjects suppresses the
activation of the IKK–NFκB pathway, as evidenced by an
increased abundance of IκB-α and IκB-β (Sriwijitkamol
et al. 2006). Although a single session of exercise is known
to reduce JNK activation (Ropelle et al. 2006; Schenk &
Horowitz, 2007), the effect of exercise training on JNK
activity is less clear. Considering the potential opposing
effects of fatty acid mobilization and exercise on the
activation of the IKK–NFκB and JNK pathways, it is
possible that the addition of exercise to a weight-loss
program may help improve insulin sensitivity at least in
part through a reduced pro-inflammatory/stress response.
The primary aim of the present study was to investigate
whether decreased fatty acid mobilization or an increase
in skeletal muscle oxidative capacity is more important
in mediating the improvement in insulin sensitivity
in response to adding an endurance exercise training
program to a weight-loss intervention. We also sought
to gain a better understanding of the effects of weight loss
(with and without exercise training) on the activation of
the pro-inflammatory JNK and IKK–NFκB pathways.
Methods
Subjects
Seventeen abdominally obese women (body mass index
(BMI): 30–40 kg m−2; waist circumference >100 cm)
participated in this study. All subjects were premenopausal
and were considered to be in good health after a
comprehensive medical examination, which included a
history and physical examination, a 12-lead electro-
cardiogram and standard blood and urine tests. No
subject was taking regular medications (except birth
control). All subjects were non-smokers, weight stable
(±2 kg) for 4–6 months and had not exercised regularly
for at least 6 months before beginning the study. Sub-
jects with type 2 diabetes, coronary heart disease, clinically
significant hypertriglyceridaemia (i.e. plasma triglycerides
>150 mg dl−1) or hypertension were excluded. Subject
characteristics are presented in Table 1. Some of these sub-
jects also participated in a previous study evaluating the
affect of weight loss and exercise training on the regulation
of intracellular fatty acid transport (Schenk & Horowitz,
2006). All subjects were fully informed of the possible
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Table 1. Subject characteristics before and after weight loss
Weight loss (WL) Weight loss + Exercise (WL + EX)
Before After % Before After %
Age (years) 30 ± 3 – – 30 ± 2 – –
Body weight (kg) 88.6 ± 2.9 78.0 ± 2.5∗ −12 ± 0% 91.9 ± 2.8 80.9 ± 2.5∗ −12 ± 0%
BMI (kg m−2) 34 ± 2 30 ± 2∗ −12 ± 0% 33 ± 1 29 ± 1∗ −12 ± 0%
% body fat 47.9 ± 1.5 44.1 ± 2.2∗ −8 ± 2% 47.1 ± 0.8 42.9 ± 1.3∗ −9 ± 2%
Fat mass (kg) 42.6 ± 2.4 34.6 ± 2.6∗ −19 ± 2% 43.4 ± 1.6 34.7 ± 1.6∗ −20 ± 2%
Fat-free mass (kg) 46.0 ± 1.1 43.4 ± 1.3∗ −6 ± 2% 48.5 ± 1.5 46.1 ± 1.5∗ −5 ± 2%
V̇O2,peak (l min
−1) 2.1 ± 0.1 2.0 ± 0.1 −3 ± 3% 2.1 ± 0.13 2.6 ± 0.1∗ +22 ± 4%
Values are means ± S.E.M. ∗P ≤ 0.01, compared with Before.
risks associated with the study and signed an informed
consent document, which was approved by the University
of Michigan Institutional Review Board, in accordance
with the Declaration of Helsinki.
Preliminary testing
Whole-body fat mass (FM) and fat-free mass (FFM)
were determined before and after weight loss using
dual-energy x-ray absorptiometry (Lunar DPX DEXA
Scanner, Madison, WI, USA). Aerobic fitness was assessed
before and after weight loss by measuring peak oxygen
uptake (V̇O2,peak) during cycle ergometer exercise. The
protocol consisted of a 4 min warm-up, followed by
a progressive increase in work rate every minute until
volitional fatigue.
Experimental procedures
An overview of the experimental design is presented in
Fig. 1. More specifically, on three separate occasions (once
before (Before) and twice after weight loss), subjects were
admitted to the General Clinical Research Center (GCRC)
at the University of Michigan hospital at 1800 h, and
stayed overnight for a ‘metabolic study’. After admission,
an intravenous catheter was placed in a hand vein for
periodic overnight blood sampling. During the two trials
after weight loss, a second intravenous catheter was placed
in a forearm vein for either an overnight infusion of
saline (After) or lipid plus heparin (After + Lipid). The
goal of the lipid-plus-heparin infusion was to increase
fatty acid mobilization back up to levels similar to that
found before weight loss, which enabled us to assess the
metabolic impact of the lower fatty acid mobilization
resulting from their weight loss. During the lipid infusion,
subjects were infused overnight with a 20% lipid emulsion
(0.2 ml kg−1 min−1; Abbott Laboratories, North Chicago,
IL, USA) and heparin (5 U kg−1 min−1; Elkins-Sinn, Inc.,
Cherry Hill, NJ, USA). Our preliminary data indicated
that this infusion rate would return plasma fatty acid
mobilization to levels similar to those found before weight
loss. A standardized meal (15 kcal kg−1 FFM) was provided
at 2000 h and subjects remained fasted until completion
of the trial the next day.
At 0700 h the next morning, a muscle biopsy was
obtained from the vastus lateralis muscle. Muscle samples
were dissected free of adipose and connective tissue,
rinsed in saline, blotted dry, frozen in liquid nitrogen,
and stored at −80◦C until analysis, as described below.
After the muscle biopsy procedure, another intravenous
catheter was placed in a forearm vein for isotope
infusion. At 0800 h, we began a 1 h constant infusion
of [L-13C]palmitate (0.04 μmol kg−1 min−1) (Cambridge
Isotope Laboratories, Andover, MA, USA) bound to
human albumin (Baxter, Deerfield, IL, USA). After 45 min
of the isotope infusion (time necessary to achieve iso-
topic equilibrium in the body (Sidossis et al. 1995)),
four arterialized blood samples were collected in 5 min
intervals from a heated hand vein for determination of
fatty acid Ra and Rd (i.e. fatty acid mobilization and
uptake). The rates of oxygen consumption (V̇O2 ) and
carbon dioxide production (V̇CO2 ) were also measured
for 20–30 min intervals at 0730 h and again at 0830 h,
using a metabolic cart (Delta Trac, Sensor Medics Yorba
Linda, CA, USA) to calculate the rate of fasting whole-body
fatty acid oxidation. After these measurements of fatty
acid metabolism, an intravenous glucose tolerance test
(IVGTT) was conducted to assess insulin sensitivity
(SI) using the minimal model technique, as previously
described (Schenk et al. 2005). After the IVGTT, sub-
jects were fed and after vital signs were stable they were
discharged from the hospital. All trials were conducted
during the first 2 weeks of the subjects’ menstrual cycle.
The two trials after weight loss were separated by at least
7 days, and for the exercise training group both trials
were conducted exactly 3 days after the subjects’ exercise
session.
Weight-loss interventions
The weight-loss intervention used in this study has
been previously described in detail (Schenk & Horowitz,
2006). Briefly, after completing the baseline metabolic
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study, subjects were instructed to reduce their caloric
intake 500–800 kcal day−1 below that required to maintain
body weight, with the goal to achieve a rate of weight
loss of 0.5–1.0 kg week−1. Subjects met weekly with our
research dietitian. After losing 12% of their initial body
weight, dietary caloric intake was increased in order to
meet the energy needs of weight maintenance, and sub-
jects were in weight maintenance (±0.5 kg) for at least
3–4 weeks before being admitted to the hospital for their
follow-up metabolic studies. Subjects in the weight-loss
treatment group (WL, n = 7) were not permitted to
exercise or increase their physical activity level. For sub-
jects in the weight-loss plus exercise treatment group
(WL + EX, n = 10), in addition to the aforementioned
dietary program, these subjects also performed supervised
exercise on a stationary bicycle ergometer for 3 days per
week for 45 min at 85% of maximum heart rate, with
one additional unsupervised session per week. Exercise
training continued throughout the weight maintenance
period. After weight loss and the weight maintenance
period, the first follow-up metabolic study was completed
exactly 3 days after exercise. Between the first and second
post-weight-loss trials, all WL + EX subjects performed
two to three exercise sessions, and again there was exactly
3 days between the last exercise session and the second
metabolic study.
Analytical methods
Plasma substrate and hormone levels. Plasma glucose
(Thermo DMA, Melbourne, Australia) and overnight
fatty acids (Waco Chemicals GmbH, Neuss, Germany)
concentrations were measured by colorimetric assay. For
samples taken during the tracer infusion, plasma palmitate
and total plasma fatty acid concentration were measured
by internal standard method using gas chromatography
with flame ionization detection (GC/FID) (Wolfe, 1992).
Plasma insulin concentration was measured by radio-
immunoassay (Linco Research, Inc., St Louis, MO, USA).
Plasma fatty acid kinetics. The tracer-to-tracee ratio
(TTR) for plasma palmitate was determined by gas
chromatography-mass spectrometry (GC-MS) with an
MSD 5973 system (Agilent Technologies; Wilmington,
DE, USA) with capillary column as previously described
(Patterson et al. 1998).
Western blotting. Whole-cell lysates were prepared as
described previously (Schenk & Horowitz, 2006). For
Western blotting, samples (25 μg) were separated by
8% SDS-PAGE and transferred in an ice bath at
200 mA. After blocking, membranes were probed for
phosphorylated-JNK (p-JNK; no. 9251, Cell Signaling,
Danvers MA, USA), JNK-1 (sc-474; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and IκB-β (nos 9242
and 9248; Cell Signaling Technology). Membranes were
then incubated in the appropriate secondary anti-
body for 60 min and were developed with enhanced
chemiluminescence (Amersham Biosciences, Piscataway,
NJ, USA). Bands were quantified by densitometry (Fluor
Chem SP, Alpha Innotech, San Leandro, CA, USA). As all
samples were not run on the same gel, or on the same
Figure 1. Overall experimental design
Subjects were admitted to the hospital for a battery of baseline metabolic tests to assess fatty acid metabolism
and insulin sensitivity (see details in Experimental procedures). Subjects were then randomized into one of two
weight-loss treatment groups: (1) weight loss through dietary intervention only (WL), or (2) weight loss through
an intervention of diet and exercise training (WL + EX) (see details in Weight-loss interventions). Subjects followed
their respective weight-loss interventions until they lost 12% of their initial body weight, at which point they were
placed on a weight-maintaining diet for 3–4 weeks before being admitted to the hospital again for their follow-up
studies. Subjects completed two separate follow-up metabolic studies. On one of these occasions subjects were
tested identically as they were before the intervention, with a constant saline infusion used as a control. On the
other occasion subjects received a low-dose lipid and heparin infusion throughout their hospital visit (see details
in Experimental procedures). These follow-up studies were separated by at least 1 week.
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day, and to control for differences in film exposure time,
band densities for each subject on each blot were expressed
relative to a standard (muscle from an obese female), which
was run in duplicate on all gels.
Calculations
Resting whole-body fatty acid oxidation was calculated
from resting V̇O2 and V̇CO2 measurements using the
equations of Frayn (Frayn, 1983). Palmitate rate of
appearance (Ra) and disappearance (Rd) were calculated
using the Steele equation for steady-state conditions
(Steele, 1959). Fatty acid Ra was calculated by dividing
palmitate Ra by the ratio of plasma palmitate to
total plasma fatty acid concentration, as measured by
GC/FID. As measurements were made under steady-state
conditions, fatty acid Ra = fatty acid Rd. The insulin
sensitivity index (SI) was calculated from least-squares
fitting of the insulin and glucose concentration curves
from the IVGTT using the Minimal Model Millennium
(version 6.02; MinMod Inc.) computer analysis software.
It must be noted that SI does not allow us to differentiate
insulin sensitivity among different tissues. However, SI
has been found to closely match insulin-stimulated
glucose disposal into skeletal muscle as measured
by the hyperinsulinaemic–euglycaemic clamp technique
(Bergman et al. 1987; Saad et al. 1994). Therefore, changes
in SI are probably reflective of changes in skeletal muscle
insulin sensitivity.
Statistics
A two-way ANOVA for repeated measures with Tukey
post hoc analysis was used to assess differences among
treatments for all parameters. Statistical significance was
set at P < 0.05. All values are presented as mean ± S.E.M.
Results
Changes in body weight and body composition
There were no differences in age, initial body weight
or body composition between the groups (Table 1). As
designed, all subjects in the WL and WL + EX groups
lost 12% of their initial body weight (Table 1). Over-
all, the time taken to reach the goal body weight
was significantly shorter in WL + EX compared with
WL (20 ± 2 vs. 30 ± 3 weeks, P < 0.01). All subjects
maintained their lower body weight for 4 weeks before
the follow-up metabolic studies. BMI, % body fat and fat
mass (FM) also declined significantly (P < 0.01), with no
differences between groups. Both weight-loss treatments
also slightly, yet significantly (P < 0.01), reduced fat-free
mass (FFM). Exercise training significantly increased
whole-body oxidative capacity, as shown by a 22 ± 4%
increase in V̇O2,peak in the WL + EX group (Table 1,
P < 0.0001). In the WL group, however, oxidative capacity
was unchanged (Table 1).
Plasma triglyceride concentration
Plasma triglyceride concentration was not affected by
weight loss in either the WL or WL + EX groups (Fig. 2).
Moreover, the lipid infusion after weight loss did not
significantly increase plasma triglyceride concentration
(Fig. 2), indicating that nearly all of the infused
triglycerides were hydrolyzed.
Fatty acid mobilization, uptake and oxidation
Plasma fatty acid concentration measured throughout
the overnight hospital visit was not significantly altered
by either of the two weight-loss treatments (Fig. 3A).
Despite the similar plasma fatty acid concentration before
and after weight loss, fatty acid mobilization and uptake
(fatty acid Ra and Rd) were more than 30% lower
(P < 0.03) after weight loss in both groups (Fig. 3B).
Importantly, during After + Lipid, fatty acid Ra and Rd
Figure 2. Plasma triglyceride concentration during the
overnight hospital visits
Open circles, before WL; black circles, after WL; grey circles,
after + Lipid WL; open triangles, before WL + EX; black
triangles, after WL + EX; grey triangles, after + Lipid
WL + EX.
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Figure 3
A, plasma fatty acid concentration during the overnight
hospital visits. Open circles, before WL; black circles, after
WL; grey circles, after + Lipid WL; open triangles, before
WL + EX; black triangles, after WL + EX; grey triangles,
after + Lipid WL + EX. B, fatty acid rate of appearance in
plasma (Ra) and disappearance from plasma (Rd) after an
overnight fast. Measurements were made before (Before)
and after (After) weight loss, and during the lipid–heparin
infusion after weight loss (After + Lipid). ∗Significantly
different from Before and After + Lipid, P < 0.05.
were increased back to pre-weight-loss levels (Fig. 3B),
and plasma fatty acid concentration was not different
from levels observed before and after weight loss (Fig. 3A).
Despite the reduction in fatty acid Rd (a measure of fatty
acid uptake), resting fatty acid oxidation was unchanged
after the intervention in WL. Consistent with an increase in
maximal oxidative capacity, resting whole-body fatty acid
oxidation was increased more than 20% after WL + EX
(Fig. 4). This increase was due to an increase in the
contribution of fatty acids to total energy expenditure (i.e.
decreased respiratory exchange ratio; P < 0.05), because
resting energy expenditure was unchanged in WL and
WL + EX (data not shown). Increasing fatty acid Ra
and Rd after weight loss during After + Lipid did not
further increase whole-body fatty acid oxidation in either
group (Fig. 4). Notably, fatty acid Ra per kilogram FM
was similar before and after weight loss (WL: 2.3 ± 0.1
vs. 2.1 ± 0.2 μmol (kg FM)−1 min−1, WL + EX: 2.5 ± 0.2
vs. 2.4 ± 0.2 μmol (kg FM)−1 min−1, Before vs. After),
which suggests that the decrease in fatty acid mobilization
after weight loss was due to a decrease in total fat
mass.
Figure 4. Whole-body fatty acid oxidation before
(Before) and after (After) subjects lost 12% of their
initial body weight, and during a lipid–heparin
infusion after weight loss (After + Lipid)
∗Significantly different from Before, P < 0.05.
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Table 2. Plasma glucose and insulin concentrations
Before After After + Lipid
Glucose (mM) WL 5.0 ± 0.2 5.0 ± 0.2 5.0 ± 0.2
WL + EX 5.1 ± 0.1 5.0 ± 0.1 4.9 ± 0.2
Insulin (μU ml−1) WL 14.1 ± 1.8 9.3 ± 1.0∗ 10.2 ± 1.3∗
WL + EX 14.8 ± 1.4 10.6 ± 1.4∗ 11.9 ± 1.4∗
Values are means ± S.E.M.
Fasting plasma glucose and insulin concentrations,
and insulin sensitivity
Fasting plasma glucose concentrations were not affected
by either weight-loss treatment (Table 2). However,
fasting plasma insulin concentration declined 30–40%
(P < 0.05) after weight loss in both groups (Table 2).
Consistent with this reduction in fasting plasma insulin
concentration, SI increased by 60–70% (P < 0.05) after
both treatments (Fig. 5), and the improvement in SI
was identical between treatments. Importantly, the lipid
infusion and the resultant increase in fatty acid Ra and Rd
completely reversed the improvement in SI after weight
loss in both groups (Fig. 5).
Skeletal muscle pro-inflammatory factors
Total JNK protein abundance was not affected by either
weight-loss intervention, or the lipid infusion. However,
p-JNK (expressed relative to total JNK abundance)
was reduced by ∼40% after weight loss in both
groups(Fig. 6A). The lipid infusion increased p-JNK
back to levels found before weight loss in the WL
group (Fig. 6A). Interestingly, although there was a trend
for the lipid infusion after weight loss in WL + EX
to increase p-JNK levels, this did not reach statistical
significance (P = 0.08), and it remained significantly
lower than Before (P < 0.05; Fig. 6A). Protein abundance
of IκB-β was significantly increased by ∼50% after
both WL and WL + EX (P < 0.05; Fig. 6B). Importantly,
the lipid infusion reduced IκB-β abundance back to
pre-weight-loss levels in both treatment groups.
Discussion
Lifestyle interventions involving weight loss and exercise
clearly improve insulin sensitivity in obese individuals,
yet the mechanisms for this effect are not well under-
stood. One of the major findings of this study was that
the reduction in systemic fatty acid mobilization and
uptake after weight loss plays a primary role in the
insulin sensitizing effects of a weight-loss intervention.
In contrast to evidence suggesting that alterations in fatty
acid oxidative capacity may be an important contributor
to the regulation of insulin sensitivity (Savage et al.
2007), our findings demonstrate that a marked elevation
in oxidative capacity after WL + EX did not improve
insulin sensitivity any more than WL. Moreover, we found
that improved fatty acid oxidative capacity after exercise
training was not sufficient to prevent insulin resistance
when fatty acid flux was returned to pre-weight-loss levels
with the lipid infusion during After + Lipid. Our findings
also indicate that the improved insulin sensitivity after
weight loss may in part be due to a reduction in the
pro-inflammatory/stress response in skeletal muscle.
The excessive fatty acid mobilization, such as that found
in persons with abdominal obesity (Horowitz et al. 1999b),
is known to potently impair insulin sensitivity (Griffin
et al. 1999; Roden et al. 2000; Itani et al. 2002). Here
we demonstrated that a 30% reduction in fatty acid Rd
Figure 5. Insulin sensitivity index (SI) before (Before)
and after (After) subjects lost 12% of their initial body
weight, and during a lipid–heparin infusion after
weight loss (After + Lipid)
∗Significantly different from Before and After + Lipid,
P < 0.05.
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(i.e. fatty acid uptake) after weight loss, regardless of
whether or not the participant increased their aerobic
fitness through exercise training, was accompanied by a
> 60% improvement in insulin sensitivity. This is in line
with studies in which insulin sensitivity was significantly
enhanced after fatty acid mobilization was reduced by
pharmacological inhibition of lipolysis (Santomauro et al.
1999; Bajaj et al. 2005). Our novel finding that the
improvement in insulin sensitivity was effectively reversed
when fatty acid Ra and Rd were returned to levels found
before the intervention (via a lipid and heparin infusion;
After + Lipid) indicates that the primary mediator of the
improvement in insulin sensitivity after weight loss was
a reduction in fatty acid mobilization. Mechanistically,
we believe that the decrease in fatty acid mobilization
after weight loss was simply due to the ∼8 kg decrease in
total fat mass, as fatty acid Ra per kilogram of FM, was
unchanged after weight loss. It has previously been found
that weight loss is accompanied by a ∼40% reduction in
adipose tissue hormone-sensitive lipase abundance (Klein
et al. 1996), which may also help explain the suppression
in fatty acid mobilization after weight loss.
Interestingly, when weight loss is not accompanied by
a reduction in fatty acid mobilization, insulin sensitivity
is not improved (Klein et al. 2004). A study by Klein et al.
(2004) reported that large-scale liposuction that resulted
in the removal of a substantial amount of body fat (i.e.
∼10 kg of body fat) did not reduce fatty acid mobilization,
and insulin sensitivity was not improved. The reason
why the liposuction treatment did not reduce fatty acid
mobilization is not clear, but may be due to the removal
of fat cells with the liposuction procedure, which sub-
sequently may reduce the ability of the body to sequester
fatty acids. Other studies using conventional weight-loss
programs (i.e. caloric restriction without surgery) have
also reported that fatty acid mobilization and/or lipolytic
rate is not decreased by weight loss, or may even be elevated
(Kanaley et al. 1993; Vazquez & Kazi, 1994). In these
Figure 6
A, abundance of phosphorylated c-Jun NH2-terminal kinase
(p-JNK) expressed relative to total JNK-1 abundance
(arbitrary units) and B, protein abundance of inhibitor κB
(IκB)-β in muscle biopsy samples obtained before (Before)
and after (After) subjects lost 12% of their initial body
weight, and during a lipid–heparin infusion after weight
loss (After + Lipid). Inset, Western blots of p-JNK, total JNK
and IκB-β abundance from two representative subjects.
∗Significantly different from Before. †Significantly different
from After + Lipid, P < 0.05. nsb, non-specific binding.
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studies, however, lipolytic rate or fatty acid mobilization
were measured while the subjects were still in a negative
energy balance, which is a time when the hormonal
milieu (e.g. elevated catecholamine and suppressed insulin
concentrations) is conducive for an elevated lipolytic
rate. Therefore, measuring fatty acid mobilization when
subjects are still in a negative energy balance does not
accurately reflect the impact of the weight loss, per se.
Studies measuring fatty acid mobilization during a period
of weight stability after weight loss agree with our findings
that weight loss results in a marked reduction in fatty
acid mobilization, along with a concomitant improvement
in generalized markers for insulin sensitivity (i.e. fasting
insulin and/or homeostasis model assessment (HOMA))
(Klein et al. 1996; Lofgren et al. 2002; Thyfault et al. 2004).
Similar to findings from Ross and colleagues (Ross
et al. 2000; Janssen et al. 2002) and more recently
Toledo et al. (Toledo et al. 2008), we found that adding
exercise training to a weight-loss program did not improve
insulin sensitivity any more than weight loss without
exercise training. Our observation that exercise training
did not prevent fatty acid-induced insulin resistance in
After + Lipid, is also consistent with a cross-sectional
study that demonstrated that a lipid infusion impaired
insulin sensitivity to a similar extent in both endurance
exercise-trained and sedentary individuals (Matzinger
et al. 2002). Importantly, the observation that exercise
training does not augment insulin sensitivity appears to
be contingent on removing the transient effects of the
most recent session of exercise (Ivy et al. 1983; Mikines
et al. 1989). In line with this, the subjects in our WL + EX
group did not perform exercise for 3 days before the
follow-up tests, and subjects in the studies by Ross and
colleagues (Ross et al. 2000; Janssen et al. 2002; Dekker
et al. 2007) and Toledo et al. (Toledo et al. 2008) were tested
at least 3 days after their last exercise session. Our sub-
jects, however, clearly responded to the exercise training
intervention as demonstrated by their significant increase
in whole-body aerobic capacity (i.e. V̇O2,max), increased
protein abundance of mitochondrial proteins (e.g. COX-I
and CPT-I) in skeletal muscle (reported previously:
Schenk & Horowitz, 2006), as well as increased resting fatty
acid oxidation. Nevertheless, this enhancement in fatty
acid oxidative capacity in WL + EX did not translate into
an additive improvement in insulin sensitivity compared
with WL, nor did it appear to be the mediator of improved
insulin sensitivity after WL + EX. That is, because our
lipid infusion reversed insulin sensitivity similarly in WL
and WL + EX, our data suggest that the reduction in fatty
acid mobilization after weight loss is the key determinant
for the weight-loss-induced increase in insulin sensitivity
regardless of whether the participants had exercise-trained
(and increased their fatty acid oxidative capacity) or not.
The impact of oxidative capacity and fatty acid
oxidation on the regulation of insulin sensitivity is
controversial. Although previous reports indicate that
insulin resistant offspring of type 2 diabetics have low
oxidative capacity (Petersen et al. 2004), improved insulin
action after exercise training in offspring of type 2 diabetics
was found to be dissociated from an increase in oxidative
capacity (Ostergard et al. 2006). Additionally, in contrast
to our finding that improved oxidative capacity did not
protect against fatty acid-induced insulin resistance, over-
expression of CPT-I, and overexpression of peroxisome
proliferator-activated receptor-γ co-activator 1 (PGC-1),
have been found to prevent fatty acid-induced insulin
resistance in vitro (Sinha et al. 2004; Koves et al. 2005),
as well as in vivo (Bruce et al. 2009). However, it is unclear
whether findings from these in vitro and animal studies
translate well to in vivo human physiology. For example,
similar to our findings, a higher capacity to oxidize fat in
lean endurance-trained subjects did not protect against
lipid-induced insulin resistance (Matzinger et al. 2002).
Similarly, non-diabetic Asian Indians have been found to
be highly insulin resistant when compared to northern
Europeans controls, despite their skeletal muscle having
a greater capacity for oxidative phosphorylation (Nair
et al. 2008). Perhaps most relevant to our present findings,
it is important to recognize that even when endurance
training is found to induce a significant increase in resting
fatty acid oxidation in vivo (as in the present study), the
magnitude of this increase is typically very small (i.e.
10–20 μmol min−1), especially when compared with the
rate of fatty acid mobilization in persons with abdominal
obesity (i.e. 400–600 μmol min−1). Accordingly, even if
fatty acid oxidative capacity is elevated, this is probably
insufficient to compensate for the excessive fatty acid
mobilization and uptake found in obesity. This perspective
is further supported by recent studies demonstrating that
although a high-fat diet in rodents increased their rates of
fatty acid oxidation and skeletal muscle fatty acid oxidative
capacity, insulin sensitivity was still reduced because this
increase in fat oxidation (and oxidative capacity) was
insufficient to accommodate the excess fatty acid flux
(Turner et al. 2007; Hancock et al. 2008; Bruce et al.
2009).
To gain a better understanding of the mechanisms by
which weight loss improved insulin sensitivity in our study
we measured the activation of pro-inflammatory JNK and
IKK–NFκB pathways in skeletal muscle. The activation of
these pathways is elevated in skeletal muscle from obese
individuals and type 2 diabetics (Bandyopadhyay et al.
2005; Sriwijitkamol et al. 2006). Fatty acids have been
found to activate the JNK and IKK–NFκB pathways, and
increased fatty acid mobilization and obesity appears to
cause insulin resistance in skeletal muscle, at least in part,
via activation of these pathways (Hirosumi et al. 2002;
Ropelle et al. 2006). To this end, we found that weight
loss, the resultant reduction in fatty acid mobilization
and improvement in insulin sensitivity were accompanied
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by reduced p-JNK and increased IκB-β abundance (i.e.
suggestive of a reduced activation of the IKK–NFκB
pathway), and these changes occurred independently of
exercise training. To our knowledge, this is the first study
to demonstrate that weight loss reduces inflammation in
human skeletal muscle. The comparable reductions in
activation of the JNK and IKK–NFκB pathways may also
help explain the similar improvement in insulin sensitivity
between our two treatment groups. Further support for
a role of these pathways in the improvement in insulin
sensitivity after weight loss was demonstrated by our
observation that the improvement in insulin sensitivity
after weight loss was completely reversed during the
lipid infusion trials, in conjunction with a reduction
in IκB-β abundance and an elevation in p-JNK. Inter-
estingly, our finding that the increase in p-JNK with
lipid infusion during WL + EX did not quite reach
statistical significance (P = 0.08) suggests that exercise
training and/or improved oxidative capacity, may have
provided some protection against the susceptibility of JNK
activation to increase in response to an excessive fatty acid
mobilization. Nevertheless, this attenuation did not pre-
vent fatty acid-induced insulin resistance.
Despite the vast number of studies that have examined
the effects of exercise training on insulin sensitivity,
this topic remains controversial. We believe that much
of this controversy can be resolved by comparing the
experimental designs and the specific research questions
being addressed in studies in this area. Among the greatest
confounding issues in these studies is body weight loss
that often accompanies exercise/lifestyle interventions.
Since a negative energy balance clearly evokes a potent
increase in insulin sensitivity (Assali et al. 2001), it is
not surprising that an exercise training program would
enhance insulin sensitivity when the participant is studied
in a state of negative energy balance (Goodpaster et al.
2003). To accurately assess the effects of exercise training
independently of the effects of a negative energy balance it
is critical to study the participants after a period of weight
stability. In addition, because the degree of weight loss
can also affect the magnitude of metabolic adaptations,
when attempting to assess the impact of adding an exercise
training regimen to a dietary/lifestyle intervention, it is
imperative to match the weight lost by subjects in the
different interventions. Finally, because the effects of a
single session of exercise can persist for 2–3 days after
exercise (Mikines et al. 1988; Cartee et al. 1989), to evaluate
the effects of exercise training (and increased oxidative
capacity), per se, on insulin sensitivity (and independently
of the acute effects of exercise) metabolic measurements
should not be performed for at least ∼3 days after the most
recent session of exercise, and diets after the most recent
exercise session should be controlled, at least in terms of
providing enough dietary carbohydrate to fully replenish
glycogen stores. When all of these issues are accounted for,
there is a general consensus in the literature that much
of the effect of exercise training on enhancing insulin
sensitivity is primarily due to the residual effects of the
most recent exercise session, and that increasing oxidative
capacity via exercise training is not a potent enhancer of
insulin sensitivity (Ivy et al. 1983; Mikines et al. 1989;
Perseghin et al. 1996; Janssen et al. 2002; Ross et al. 2004;
Dekker et al. 2007; Toledo et al. 2008). Nevertheless, it
is very important to note that exercise training, which
represents the accumulation of numerous acute bouts of
exercise, certainly provides many benefits to metabolic and
overall health.
An important limitation of the present study was
that our measurement of insulin sensitivity (i.e. IVGTT)
measures whole-body insulin sensitivity, and does not
provide a direct measurement of skeletal muscle insulin
sensitivity. Notably, however, approximately 85% of
measured and calculated SI from the IVGTT has been
shown to be the result of insulin increasing glucose
uptake into skeletal muscle (Bergman et al. 1987).
Additionally, fatty acid-induced insulin resistance has
been found to be primarily due to defects in skeletal
muscle insulin action (Dresner et al. 1999; Itani et al.
2002). Nevertheless, undoubtedly weight loss would
result in improvements in insulin sensitivity in all major
metabolic tissues, including liver, adipose tissue and
skeletal muscle. Another limitation of the present study
was that because the Liposyn solution we infused during
the After + Lipid trials was over 60% linoleate, and only
∼10% palmitate, the accuracy of our fatty acid Ra/Rd
measurement during the lipid infusion trials requires
that palmitate kinetics resemble the kinetics for linoleate
and the other major fatty acid species. Importantly, it
has been found that fractional uptake of palmitate is
similar to many of the major fatty acid species, including
linoleate (Hagenfeldt et al. 1972), and palmitate and
linoleate are both considered to provide a reasonable
estimate of total fatty acid kinetics (Mittendorfer et al.
2003). Moreover, it has been reported that there were no
differences in the metabolism of the major individual
fatty acid species from a lipid emulsion solution similar
to that provided in our study (Fielding et al. 1999).
Additionally, our infusion rate of the exogenous 20% lipid
solution (0.2 ml kg−1 h−1) would theoretically yield an
increase in fatty acid Ra of ∼200 μmol min−1, if all fatty
acids were liberated from the infused triglycerides (TG)
(0.2 ml kg−1 h−1 × 0.2 g TG ml−1 × 1 g TG (880 mol)−1 ×
3 mol fatty acid (1 mol triglyceride)−1 × 90 kg ×
1 h (60 min)−1 = 204 μmol min−1). This theoretical
increase in exogenous fatty acid Ra matched very well
with our measured increase in fatty acids Ra between
After and After + Lipid (150–200 μmol min−1). This
provides further evidence that our tracer methods did
indeed provide an accurate reflection of whole-body fatty
acid Ra/Rd.
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In summary, enhanced insulin sensitivity after weight
loss (regardless of whether weight loss occurred via dietary
restriction alone or dietary restriction combined with
exercise training) was primarily mediated by a reduction
in fatty acid mobilization. In addition, although adding
exercise training to a dietary weight-loss intervention
increased fatty acid oxidative capacity and resting fatty
acid oxidation, these changes were not sufficient to
prevent fatty acid-induced insulin resistance. Finally, the
reduction in fatty acid mobilization and uptake after
weight loss was associated with reduced activation of
the pro-inflammatory JNK and IKK–NFκB pathways
in skeletal muscle, and thus may be an important
contributor to the weight loss-induced improvement in
insulin sensitivity.
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